Mergers and Acquisitions Sanofi Acquires Animal Health Division of Dosch Pharmaceuticals

Editor: Dominik Stephan

Sanofi on shopping spree in India: Merial, the Animal Health division of Sanofi, has entered into a binding agreement to acquire the animal health division of the Indian company Dosch Pharmaceuticals.

Related Companies

Sanofi to acquire Indian animal health company.
Sanofi to acquire Indian animal health company.
(Picture: Sanofi)

Mumbai/India – Dosch Pharmaceuticals, headquartered in Mumbai, India, was incorporated in 1992 and is a diversified pharmaceutical company, primarily operating through two divisions, animal health and exports. The animal health division being acquired by Merial has more than 86 products under 50 brands for ruminants, poultry and companion animals. Products include an extensive range of animal health therapeutics and nutritional feed supplements. Within the animal health division, Dosch has a 279 member sales force, covering 18 Indian states.

“The acquisition of Dosch’s Animal Health Division will be a significant milestone for Merial and give us a strategic platform for our development in the Indian market,” said Jose Barella, Chief Executive Officer of Merial. “We are convinced that the combination of Dosch’s animal health brands and distribution strength, along with the robust new product pipelines from both Merial and Dosch, will strongly position Merial to become rapidly a major animal health player in India.”